Discovering the Molecular Landscape of Meningioma: The Struggle to Find New Therapeutic Targets (original) (raw)

The Prognostic Value of Methylation Signatures and NF2 Mutations in Atypical Meningiomas

Sverre Torp

Cancers

View PDFchevron_right

Genetic/molecular alterations of meningiomas and the signaling pathways targeted

Alberto Orfao

Oncotarget, 2015

View PDFchevron_right

Molecular genetics of meningiomas: a systematic review of the current literature and potential basis for future treatment paradigms

Steven Giannotta

Neurosurgical focus, 2011

View PDFchevron_right

Genomic Analysis of Non- NF2 Meningiomas Reveals Mutations in TRAF7 , KLF4 , AKT1 , and SMO

Yasar Bayri

Science, 2013

View PDFchevron_right

Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities

David Raleigh

Nature Genetics

View PDFchevron_right

Meningioma genomics: a therapeutic challenge for clinicians

Shadi Bsat

Journal of integrative neuroscience, 2021

View PDFchevron_right

Genomic landscape of intracranial meningiomas

Ossama Al-mefty

Journal of neurosurgery, 2016

View PDFchevron_right

Identification of Promoter Region Methylation Patterns of MGMT , CDKN2A , GSTP1 , and THBS1 Genes in Intracranial Meningioma Patients

Nur Altinors, Salih Gulsen

Genetic Testing and Molecular Biomarkers, 2012

View PDFchevron_right

Meningioma epigenetic grouping reveals biologic drivers and therapeutic vulnerabilities

David Raleigh

2020

View PDFchevron_right

Genomic Analysis of Non- NF2 Meningiomas Reveals Mutations in TRAF7 , KLF4 , AKT1 , and SMO

Saliha YILMAZ

Science, 2013

View PDFchevron_right

Meningioma: A Pathology Perspective

Kristin Huntoon

Neurosurgery, 2021

View PDFchevron_right

Molecular and translational advances in meningiomas

Warren Selman

Neuro-Oncology, 2018

View PDFchevron_right

Clinical Significance of Molecular Alterations and Systemic Therapy for Meningiomas: Where Do We Stand?

Alessia Pellerino

Cancers

View PDFchevron_right

An integrated genomic analysis of anaplastic meningioma identifies prognostic molecular signatures

Ramez Kirollos

View PDFchevron_right

DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis

Andreas Unterberg

The Lancet. Oncology, 2017

View PDFchevron_right

Molecular Profiling of 22 Primary Atypical Meningiomas Shows the Prognostic Significance of 18q Heterozygous Loss and CDKN2A/B Homozygous Deletion on Recurrence-Free Survival

Giampietro Pinna

Cancers, 2021

View PDFchevron_right

Integrated genomic analyses of de novo pathways underlying atypical meningiomas

Burçin Baran

Nature communications, 2017

View PDFchevron_right

Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively Validated

Annika Wefers

Journal of Clinical Oncology, 2021

View PDFchevron_right

Integrative Genomic Analysis Identifies NDRG2 as a Candidate Tumor Suppressor Gene Frequently Inactivated in Clinically Aggressive Meningioma

Michael Chicoine

Cancer Research, 2005

View PDFchevron_right

Chromosomal alterations, prognostic factors, and targeted molecular therapies for malignant meningiomas

Daniel Nagasawa, Isaac Yang

Journal of Clinical Neuroscience, 2013

View PDFchevron_right

Methylation status of MGMT gene promoter in meningiomas

Sanjog Kalra

Cancer Genetics and Cytogenetics, 2008

View PDFchevron_right

Epigenetics of Meningiomas

László Bognár

BioMed Research International, 2015

View PDFchevron_right

Molecular pathogenesis of meningiomas

David Gutmann

Journal of Neuro-Oncology, 2004

View PDFchevron_right

Recent advances in managing/understanding meningioma

Karan Dixit

F1000Research

View PDFchevron_right

Meningioma: A Review of Clinicopathological and Molecular Aspects

Kristin Huntoon

Frontiers in Oncology, 2020

View PDFchevron_right

ARID1A and TERT promoter mutations in dedifferentiated meningioma

Wenya Bi

Cancer Genetics, 2015

View PDFchevron_right

Genomic Landscape of Meningiomas

Jun Dong

Brain Pathology, 2009

View PDFchevron_right

Oncogenic PI3K mutations are as common asAKT1andSMOmutations in meningioma

Ossama Al-mefty

Neuro-Oncology, 2016

View PDFchevron_right

Molecular Biological Determinations of Meningioma Progression and Recurrence

Stefan Linsler

PLoS ONE, 2014

View PDFchevron_right